相关实验视频

Updated: Sep 10, 2025

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

中国的CAR-T细胞疗法:创新,挑战和战略途径

Lihui Yan¹, Boshi Duan², Peng Sun³

¹Department of Pain Relief Therapeutic, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, China.

Discover oncology

|August 22, 2025

概括

中国在血液癌症治疗中推进了CAR-T细胞疗法,达到全球标准. 创新策略和政策变化正在扩大获取机会, 解决未来癌症免疫治疗的严峻挑战.

科学领域:

癌症学
免疫疗法
细胞疗法

背景情况:

化学抗原受体T细胞 (CAR-T) 治疗是血液恶性瘤的关键个性化治疗方法.
中国在CAR-T开发方面取得了重大进展,与全球血液癌症临床结果相匹配.

研究的目的:

审查中国在CAR-T治疗方面的进展,包括对固体瘤的创新和可访问性.
突出解决CAR-T局限性的策略,如抗原异质性和免疫抑制瘤微环境.

主要方法:

开发双目标的CAR-T,装备有细胞因子的CAR-T,并与中国传统医学 (TCM) 进行整合.
实施政策创新,如"1+3+N"支付系统,以提高负担能力.
投资于自动化制造和追求全球监管协调.

主要成果:

在B细胞恶性瘤中,总体应答率高 (79% - 89%),在多发性骨髓瘤中,无进展的12个月存活率为64%.
临床前证据显示TCM (黄金) 在肺癌模型中增强了CAR- T的疗效.
政策改革将患者的费用降低50%,

结论:

中国是成本效益高的CAR-T研发领域的领导者,
瘤向,国际整合和长期安全仍然存在挑战.
未来的重点包括精密工程,人工智能和下一代CAR-T疗法的合作.

关键词:

双特异性抗体卡尔-T 免疫细胞治疗免疫检查点治疗癌症免疫疗法

更多相关视频

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.